Search research articles
Contact Us
Filters
Showing results (51-60 of 170) with videos related to
Page
of 17
Sort By:
Blood Cancer Journal
|
March 22, 2022
Extramedullary disease in multiple myeloma: a systematic literature review
Joan Bladé, Meral Beksac, Jo Caers, et al.
Annals of Hematology
|
February 12, 2021
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns
Sophia Danhof, Leo Rasche, Anja Mottok, et al.
Clinical Nuclear Medicine
|
May 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine
|
March 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Journal of Cancer Research and Clinical Oncology
|
July 19, 2023
A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials
Anna Fleischer, Larissa Zapf, Johannes Allgaier, et al.
Journal of Hematology & Oncology
|
June 7, 2022
Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
David Kegyes, Catalin Constantinescu, Louise Vrancken, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Timing antigenic escape in multiple myeloma treated with T-cell redirecting immunotherapies
Marios Papadimitriou, Sungwoo Ahn, Benjamin Diamond, et al.
Journal of Clinical Medicine
|
July 21, 2019
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research
Sophia Loda, Jonathan Krebs, Sophia Danhof, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 16, 2019
Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11
Johannes Duell, Dragana S Lukic, Margarete Karg, et al.
Cancers
|
April 29, 2020
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease
Xiang Zhou, Patricia Flüchter, Katharina Nickel, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 170) with videos related to
Sort By:
Page
of 17
Blood Cancer Journal
|
March 22, 2022
Extramedullary disease in multiple myeloma: a systematic literature review
Joan Bladé, Meral Beksac, Jo Caers, et al.
Annals of Hematology
|
February 12, 2021
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns
Sophia Danhof, Leo Rasche, Anja Mottok, et al.
Clinical Nuclear Medicine
|
May 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine
|
March 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Journal of Cancer Research and Clinical Oncology
|
July 19, 2023
A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials
Anna Fleischer, Larissa Zapf, Johannes Allgaier, et al.
Journal of Hematology & Oncology
|
June 7, 2022
Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
David Kegyes, Catalin Constantinescu, Louise Vrancken, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Timing antigenic escape in multiple myeloma treated with T-cell redirecting immunotherapies
Marios Papadimitriou, Sungwoo Ahn, Benjamin Diamond, et al.
Journal of Clinical Medicine
|
July 21, 2019
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research
Sophia Loda, Jonathan Krebs, Sophia Danhof, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 16, 2019
Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11
Johannes Duell, Dragana S Lukic, Margarete Karg, et al.
Cancers
|
April 29, 2020
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease
Xiang Zhou, Patricia Flüchter, Katharina Nickel, et al.
Page
of 17